Deep Space Biology

Chronic space radiation on astronauts reveals intriguing cellular mechanisms involved in telomere repair. Chronic exposure to space radiation results in continuous damage to telomeres, driven by elevated levels of oxidative stress and a persistent telomere-specific DNA damage response. Key cellular mechanisms in telomere repair include a complex interplay of responses: - The Telomere Damage Response triggers increased transcription of TERRA in the face of repetitive damage. - Formation of Protective Structures involves TERRA hybridizing at broken telomeres to create telomeric DNA:RNA hybrids, acting as shields for damaged telomeres. - Repair Mechanisms employ RNA templated/HR-directed repair and transient activation of ALT, contributing to telomere elongation during spaceflight. Understanding these mechanisms is crucial for developing effective countermeasures to safeguard astronauts from long-term space radiation effects and potentially advancing strategies for mitigating aging and diseases related to telomere damage on Earth. Despite the challenges posed by space radiation, the intricate cellular processes involving TERRA and telomeric hybrids offer promising avenues for telomere protection and repair. Check out the SOMA Nature Portfolio link below! https://lnkd.in/ebmXKTUk Deep Space Biology

Congratulations to The Kingdom of Saudi Arabia and The United States of America on the signed agreement on strategic cooperation aimed at strengthening bilateral cooperation in the fields of aeronautics and the exploration and use of aerospace and outer space for peaceful purposes. https://lnkd.in/dhgU-P5b وكالة الفضاء السعودية | Saudi Space Agency NASA - National Aeronautics and Space Administration

At Deep Space Biology, we recognize the profound potential of Large Language Models (LLMs) to revolutionize healthcare through enhanced data analysis and decision support. However, we must not overlook the ethical concerns surrounding fairness, bias, transparency, and privacy. As pioneers in the intersection of AI, space and biotechnology, we emphasize the critical need for well-defined ethical guidelines and continuous human involvement. Only by addressing these ethical challenges head-on can we fully harness the benefits of LLMs while ensuring they serve all communities equitably and responsibly. Since the release of ChatGPT in 2022, Large Language Models (LLMs) have shown great promise in healthcare, enhancing clinical decision-making, diagnosis, and patient communication. However, these advancements come with ethical concerns such as the spread of inaccurate medical information, privacy breaches, and biases related to gender, culture, or race. Despite these issues, comprehensive studies addressing the ethical challenges of LLMs in healthcare are lacking. To address this gap, researchers conducted a systematic review to map the ethical landscape of LLMs in healthcare, identifying potential benefits and harms. https://lnkd.in/d7N8bjNZ By Priyanjana Pramanik MSc. Reviewed by Lily Ramsey News Medical #HealthcareInnovation #AI #Bioinformatics #EthicalAI #PatientSafety #DataTransparency #FairnessInAI #DeepSpaceBiology #ClinicalDecisionSupport #LLMs #HealthcareEthics #ResponsibleAI #FutureOfHealthcare #MedicalAI #DataPrivacy

We are thrilled to announce that Deep Space Biology and SpacePharma have joined forces by signing a Memorandum of Understanding (MOU). This partnership marks a significant step towards growing and developing space microgravity research to solve complex diseases and health challenges on Earth. Together, we aim to leverage our combined expertise and resources to drive innovation and bring groundbreaking healthcare solutions from space to our planet. 🌎 Stay tuned for more updates on this exciting collaboration! #DeepSpaceBiology #SpacePharma #MicrogravityResearch #SpaceHealth #HealthInnovation #SpaceTech #MedicalBreakthroughs #SpaceCollaboration #InnovativeHealthcare #FutureOfHealth #ScientificPartnership #SpaceScience #GroundbreakingResearch

We are thrilled to announce that Deep Space Biology has been recognized as an industry key player in the rapidly evolving space biotech sector along our partners SpacePharma, BioAstra and many other incredible space biotech pioneers. This acknowledgment is featured in a comprehensive report developed by Space Impulse, Cx Bio, and SpaceRadar. This important market report highlights the significant growth and innovation within the space biotech industry, driven by the unique conditions of space that offer unparalleled opportunities for biomedical research and technological advancements. This recognition underscores our commitment to pioneering the future of biotechnology both in space and on Earth. Here is a Summary:  Space Biotech Industry Leadership and Market Dynamics The space industry is undergoing a transformation, with private companies spearheading space exploration and technological innovation. A new frontier within this domain is space biotechnology, a sector poised for substantial growth due to the unique research opportunities provided by microgravity and other space conditions. Market Potential and Drivers & Revenue Growth: McKinsey & Company estimates that the pharmaceutical industry could capture an additional $3-4 billion in revenue by collaborating with the space biotech sector. The report provides a detailed market map of over 90 space biotech companies, including Deep Space Biology, categorized into various fields such as general health applications, cell therapy, organoids and tissues, drug R&D, and big pharma ventures in space. The space biotech industry is set for significant growth, driven by the need for sustainable life support systems, advanced biomanufacturing, and innovative health solutions for space missions. Deep Space Biology remains committed to advancing biotechnology and health discoveries through cutting-edge research and international collaborations. #futureofhealthcare #spacebiotech #deepspacebiology #yotta #spaceimpulse #spaceradar #cxbio #AI #Biotech #precisionmedicine

Exciting news from Yotta, the world’s first AI-driven Space Biotech platform! With over 20 years of unparalleled space biology research, Yotta is propelling advancements in health and scientific discoveries. By revolutionizing the biopharma and biotech industries, Yotta, by Deep Space Biology is accelerating discovery and development processes like never before. Why Yotta? - Unmatched Discovery Speed: Yotta leverages proprietary algorithms to accelerate research and discovery processes exponentially. - Transformative Research: Built on extensive 20 years of space biology research, Yotta provides unique multiomic insights into cellular behavior, disease mechanisms, and more, crucial for developing novel treatments and improving human health. - Innovative AI Integration: Yotta's cutting-edge AI capabilities analyze vast datasets with precision, uncovering patterns and correlations that traditional methods might miss, leading to more accurate predictions and effective solutions for complex biological challenges. Recent Breakthroughs: Yotta, in collaboration with a major healthcare institution, has made significant discoveries in Non-Alcoholic Fatty Liver Disease (NAFLD), identifying novel therapeutic targets, paving the way for new treatments and improved patient outcomes. NAFLD is a genetic condition that effects 25% of the global population. Recognized Innovation: Yotta has been honored by CODEX as one of the World's Top 50 Innovators 2024 and recognized by StartUs Insights as one of the Top Ten Space Tech Startups to Watch, showcasing Yotta’s transformative potential and dedication to advancing health and scientific research. This year NASA GeneLab recognized Deep Space Biology as a success story. Ready to revolutionize your research? Schedule a call today with us to learn how our AI Space Biotech platform can benefit you. Explore our capabilities and discuss potential collaborations. Contact us at [email protected] or visit our website at www.deepspacebio.bio Deep Space Biology is pioneering the intersection of Space and Health for a Better Tomorrow. #SpaceBiotech #AIBiotech #SpaceResearch #HealthTech #YOTTA #DeepSpaceBiology #YottaPlatform #Innovation #BiotechRevolution #FutureOfHealth #Scientific Montana Bilger Guillermo Delgado Aparicio Michael Boerrigter

Microgravity research in space offers unique conditions that significantly accelerate the development of drugs and treatments for complex diseases on Earth. In microgravity, cellular processes and biological interactions occur differently than they do under the influence of Earth's gravity, enabling researchers to observe phenomena that are otherwise obscured. For example, protein crystallization, an essential step in drug design, is more efficient in microgravity, producing higher-quality crystals that are crucial for understanding disease mechanisms and developing precise pharmaceuticals. This can lead to the identification of new drug targets and more effective treatments, expediting the drug development pipeline. The urgent need for new treatments is underscored by the staggering $2 billion average cost and the decade-long timeline typically required to bring a new drug to market, coupled with a high failure rate. By leveraging the unique environment of space, researchers can potentially reduce both the time and cost associated with drug discovery. Microgravity conditions have been shown to accelerate the growth of certain cells, including cancer cells, allowing scientists to study their behavior and test potential treatments more rapidly than on Earth. This accelerated research pace is crucial for addressing pressing medical challenges, including cancer, neurodegenerative diseases, and antibiotic-resistant infections. Moreover, space-based research initiatives foster innovation and collaboration across industries and international borders, pooling resources and expertise to tackle some of the most intractable health problems. Space agencies, biotech companies, and research institutions are increasingly investing in microgravity research, recognizing its potential to transform drug discovery and development. As humanity faces a growing burden of complex diseases, the utilization of space microgravity research not only promises more effective treatments but also contributes to a more efficient and resilient global health system. By harnessing the potential of space, we can significantly advance medical science and improve health outcomes for millions worldwide. Deep Space Biology #SpaceResearch #Microgravity #DrugDiscovery #MedicalInnovation #SpaceHealth #Biotech #FutureOfMedicine #AcceleratedResearch #HealthTech #GlobalHealth #SpaceforEarth

As an official global winner of the @Boryung led Humans In Space Challenge, @deepspacebiology is thrilled to encourage other pioneers in healthcare-driven spacetech to apply. Space for Earth! Many health care technologies we use every single day innovated in space. CT Scan, Insulin Pump, Robotics and Wearables are just scratching the surface. This prestigious competition highlights the importance of innovative solutions at the intersection of space exploration and healthcare. By participating, you will have the opportunity to address critical challenges faced by astronauts, such as prolonged exposure to microgravity, radiation, and isolation. This platform not only offers visibility and validation for your groundbreaking work but also provides access to a network of industry experts, potential collaborators, and funding opportunities. Pushing the boundaries of healthcare in space, and contribute to the future of safe, sustainable space missions. Apply now to be part of this pioneering journey and make a lasting impact on human health beyond Earth. Learn more https://lnkd.in/gQZ3AZYp #SpaceTech #HealthcareInnovation #HumansInSpace #FutureOfHealth #deepspacebiology #SpaceExploration #InnovationChallenge #HealthcareRevolution #AstroHealth #TechForGood #PioneeringHealthcare

𝗪𝗲 𝗛𝗮𝘃𝗲 𝗩𝗲𝗿𝘆 𝗘𝘅𝗰𝗶𝘁𝗶𝗻𝗴 𝗡𝗲𝘄𝘀 𝘁𝗼 𝗦𝗵𝗮𝗿𝗲: 𝗗𝗲𝗲𝗽 𝗦𝗽𝗮𝗰𝗲 𝗕𝗶𝗼𝗹𝗼𝗴𝘆 & 𝗙𝗮𝗿𝗰𝗮𝘀𝘁 𝗕𝗶𝗼𝘀𝗰𝗶𝗲𝗻𝗰𝗲𝘀 𝗛𝗮𝘃𝗲 𝗣𝗮𝗿𝘁𝗻𝗲𝗿𝗲𝗱 𝘁𝗼 𝗥𝗲𝘃𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝗶𝘇𝗲 𝗖𝗮𝗻𝗰𝗲𝗿 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝘄𝗶𝘁𝗵 𝗔𝗜 & 𝗕𝗶𝗴 𝗗𝗮𝘁𝗮! We've joined forces in a groundbreaking partnership. By combining our AI platform, Yotta, with Farcast's tumor microdynamics data, we're poised to redefine cancer treatment. This collaboration promises to unveil unprecedented insights into tumor mechanisms and therapeutic targets, paving the way for precision-designed therapies. Read the press release here: https://lnkd.in/e_CMC7qf Deep Space Biology Farcast Biosciences Montana Bilger Kimberly Washington Guillermo Delgado Aparicio Michael Boerrigter Mohit Malhotra Satish Sankaran #deepspacebiology #DeepSpaceBiology #FarcastPartnership #CancerResearch #FarcastBio #PrecisionMedicine #AIinHealthcare #SpaceBiotech #InnovationInScience #AI #Cancer #Yotta #CancerTreatment #HopeForTheFuture #futureofhealthcare

🚀 We are thrilled to welcome Patricia (Savi) Glowe as the newest member of our Advisory Board at Deep Space Biology! Savi brings a wealth of experience and expertise to our team. As the Co-Founder and CEO of BioAstra, a pioneering non-profit organization at the forefront of blending research and technology for addressing human health challenges in space environments, Savi has demonstrated an unparalleled dedication to advancing medical technologies aimed at optimizing human health beyond Earth. Prior to her work at BioAstra, Savi spent a decade in leadership roles at the Icahn School of Medicine at Mount Sinai, spearheading initiatives in digital health technologies, translational data science, and precision health. Her commitment to innovative healthcare solutions and democratized access to data has been evident throughout her career. With a background marked by leadership in various startup organizations focused on clinical research innovation and early-stage technology adoption, Savi's expertise lies at the intersection of healthcare, technology, and clinical research. Her decades of experience in data science, executive strategy, and technology development are invaluable assets to our team. Join us in welcoming Savi as we continue our mission to explore the frontiers of deep space biology and pave the way for humanity's future beyond Earth! #DeepSpaceBiology #AdvisoryBoard #SpaceHealth #Innovation #WelcomeSavi #BioAstra